LRP5 and LRP6 comprise a subfamily of lipoprotein-receptor related proteins that function as co-receptors for Wnt proteins. Mutation of human LRP5 is responsible for osteoporosis-pseudoglioma syndrome and disruption of Lrp6 in mice causes similar effects to mutation of several different Wnt genes. We have cloned Xenopus homologues of Lrp5 and Lrp6 (Xlrp5, Xlrp6) and examined their expression during embryogenesis. Both genes are expressed maternally and ubiquitously through early development. At later stages, Xlrp5 is found in the eye, forebrain, hindbrain, branchial arches and the tip of the tail bud. Xlrp6 is expressed throughout the central nervous system, branchial arches, in the eye and otic vesicle. Both genes are also expressed at the intersomitic boundary. These results suggest roles for Wnt signaling via LRP proteins in these tissues. q
Results and discussion
Wnt proteins are secreted glycoproteins that exhibit pleiotropic effects on their target cells including growth, differentiation, morphogenesis and stem cell maintenance. Recently, Drosophila ARROW and vertebrate LRP5 and LRP6 , proteins of the LDL receptor-related (LRP) family of transmembrane receptors, were found to have key roles as Wnt co-receptors (Pinson et al., 2000; Tamai et al., 2000; Wehrli et al., 2000) . Importantly, targeted disruption of Lrp6 in mice produces defects similar to those seen in mutations of individual Wnt genes (Pinson et al., 2000) and overexpression of Lrp6 in Xenopus mimics Wnt activity (Tamai et al., 2000) . Mutations in human LRP5 underlie osteoporosis-pseudoglioma syndrome (OPPG), a disease that causes low bone mass and disrupted eye development, but do not phenocopy Wnt mutations (Gong et al., 2001) . Also, the Wnt inhibitor dickkopf (Dkk-1) is thought to block Wnt signaling through antagonism of LRP5 and LRP6 (Bafico et al., 2001; Mao et al., 2001; Semenov et al., 2001) . The expression of Lrp5 during mouse embryogenesis has not been described, however, Lrp6 was reportedly expressed in all embryonic cells (Pinson et al., 2000) .
To begin to study the role of LRP5/6 signaling in early Xenopus development, we isolated and cloned Xenopus homologues of LRP5 and LRP6 and determined their expression patterns in Xenopus embryos. Comparisons of the Xlrp5 and Xlrp6 translated amino acid sequences showed a high degree of similarity to other members of the LRP family. Xlrp5 showed 77% identity/85% similarity to human LRP5 and 76% identity/84% similarity to mouse Lrp5 (Fig. 1A) . Xlrp6 was slightly more similar showing 81% identity/88% similarity to both human and mouse Lrp6 proteins (Fig. 1B) . Similarity to the Drosophila homologue ARROW was less: 41% identity/57%similarity (not shown). Xlrp5 and Xlrp6 are also highly similar to each other and are very well conserved in the YWTD motifs, EGF-precursor domains, LDLR ligand-binding domains and in the C-terminal domain (Fig. 1C) .
We examined the expression of Xlrp5 and Xlrp6 RNAs during development by in situ hybridization. Xlrp6 and Xlrp5 are both expressed maternally in oocytes in an unlocalized fashion. Transcripts accumulate throughout early stage oocytes and become concentrated at the animal pole of mature stage VI oocytes ( Fig. 2A) . The staining pattern for Xlrp6 during gastrula and neurula stages was weak and ubiquitous but showed enriched expression in the neural plate and dorsal tissues (Fig. 2B) . Our data support the findings of Tamai et al. (2000) that show Xlrp6 expression at all stages of early embryogenesis. Xlrp5 was even more weakly expressed but expressed in a similar pattern (not shown).
At early tailbud stages, Xlrp5 and Xlrp6 appear enriched in several distinct tissues. Xlrp5 shows prominent hindbrain and notochord staining (Fig. 2C) . The hindbrain staining was varigated along the length of the hindbrain. Staining was also detected in the forebrain, the retina of the eye and at the intersomitic boundary (Fig. 2C) . Xlrp6 was expressed in a slightly different pattern. Xlrp6 transcripts were detected predominantly in head tissues including the eye, branchial arches, otic and olfactory placodes (Fig. 2D) . In contrast to Xlrp5, Xlrp6 expression was found in the spinal cord as well as uniformly throughout the brain. Xlrp6 staining was also evident at the intersomitic boundary. By the late tailbud stages, Xlrp5 expression was no longer detected in the notochord but strong staining remained in the forebrain, hindbrain and eye (Fig. 2C 0 ). Xlrp5 expression was also found in the branchial arches, otic vesicle and the tip of the tailbud. Weak staining remains at the intersomitic boundary (Fig. 2C  0 ) . By the late tailbud stage, Xlrp6 expression in the head was essentially unchanged. Expression was lost from the intersomitic boundary but weak Xlrp6 expression can be seen in the foregut endoderm (Fig. 2D  0 ) .
Sections of Xlrp5 and Xlrp6 stained embryos revealed that their expression within the neural tube is restricted to the dorsal ventricular surfaces with Xlrp5 occupying a smaller domain than Xlrp6 (Fig. 2E-G ). Xlrp6 expression in the spinal cord appears to be uniform both dorsoventrally and mediolaterally (not shown).
Experimental procedures
2.1. 5 0 and 3 0 RACE and cloning An EST was identified for Xlrp5 (GenBank Acc. # BG017115) and was obtained from the IMAGE EST consortium via the American Type Culture Collection (ATCC). This clone was sequenced on both strands and primers were designed for 5 0 RACE according to the parameters described in the Clontech SMART RACE cDNA kit. For Xlrp6, primers for 5 0 and 3 0 RACE were designed using sequence contained in the GenBank EST database (GenBank Acc. # AF276084). Primers for a second round of 5 0 RACE (5 0 RACE-2) were designed following sequencing of the initial 5 0 RACE products. 5 0 and 3 0 RACE products were generated using the SMART RACE protocol for touchdown polymerase chain reaction (PCR) and cloned into pCRII-TOPO TA vector (Invitrogen) according to the manufacturer's instructions. Three independent clones for each RACE reaction were sequenced to generate a consensus sequence, which was assembled into full-length sequences for Xlrp5 and Xlrp6 in MacVector (Oxford Molecular). Primers used for Xlrp5: 5 0 RACE-1 5 0 -GATGAGG-CTCCTGTCACGTGGTTCC-3 0 , 5 0 RACE-2 5 0 -TCGAGA-GCAGATGCCTCTTTGACTCCA-3 0 ; and for Xlrp6: 
Whole-mount in situ hybridization
Whole-mount in situ hybridizations were performed according to the method of Harland (1991) . Embryos were bleached following staining and photographed in Murray's clear (2:1 benzyl benzoate:benzyl alcohol). Stained embryos were embedded in Paraplast X-tra (Fisher) and sectioned.
